Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1985 1
1989 1
1991 4
1992 2
1993 12
1994 10
1995 20
1996 9
1997 7
1998 4
1999 4
2000 9
2001 9
2002 9
2003 2
2004 1
2005 2
2006 4
2007 3
2008 6
2009 2
2010 2
2011 3
2012 7
2013 11
2014 8
2015 10
2016 6
2017 4
2018 6
2019 4
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21249704

185 results

Results by year

Filters applied: . Clear all
Page 1
Felbamate as an add-on therapy for refractory epilepsy.
Shi LL, Dong J, Ni H, Geng J, Wu T. Shi LL, et al. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008295. doi: 10.1002/14651858.CD008295.pub2. Cochrane Database Syst Rev. 2011. PMID: 21249704 Updated. Review.
Felbamate as an add-on therapy for refractory epilepsy.
Shi LL, Dong J, Ni H, Geng J, Wu T. Shi LL, et al. Cochrane Database Syst Rev. 2014 Jul 18;(7):CD008295. doi: 10.1002/14651858.CD008295.pub3. Cochrane Database Syst Rev. 2014. PMID: 25036694 Updated. Review.
Felbamate as an add-on therapy for refractory partial epilepsy.
Shi LL, Dong J, Ni H, Geng J, Wu T. Shi LL, et al. Cochrane Database Syst Rev. 2017 Jul 18;7(7):CD008295. doi: 10.1002/14651858.CD008295.pub4. Cochrane Database Syst Rev. 2017. PMID: 28718506 Free PMC article. Updated. Review.
Felbamate add-on therapy for drug-resistant focal epilepsy.
Shi LL, Bresnahan R, Martin-McGill KJ, Dong J, Ni H, Geng J. Shi LL, et al. Cochrane Database Syst Rev. 2019 Aug 1;8(8):CD008295. doi: 10.1002/14651858.CD008295.pub5. Cochrane Database Syst Rev. 2019. PMID: 31425617 Free PMC article. Updated.
Felbamate add-on therapy for drug-resistant focal epilepsy.
Shi LL, Bresnahan R, Martin-McGill KJ, Dong J, Ni H, Geng J. Shi LL, et al. Cochrane Database Syst Rev. 2022 Aug 1;8(8):CD008295. doi: 10.1002/14651858.CD008295.pub6. Cochrane Database Syst Rev. 2022. PMID: 35914010 Free PMC article. Review.
Lamotrigine add-on for drug-resistant partial epilepsy.
Ramaratnam S, Panebianco M, Marson AG. Ramaratnam S, et al. Cochrane Database Syst Rev. 2016 Jun 22;2016(6):CD001909. doi: 10.1002/14651858.CD001909.pub2. Cochrane Database Syst Rev. 2016. PMID: 27329345 Free PMC article. Updated. Review.
Tiagabine add-on for drug-resistant partial epilepsy.
Pulman J, Marson AG, Hutton JL. Pulman J, et al. Cochrane Database Syst Rev. 2012 May 16;5(5):CD001908. doi: 10.1002/14651858.CD001908.pub2. Cochrane Database Syst Rev. 2012. PMID: 22592677 Free PMC article. Updated. Review.
Tiagabine add-on for drug-resistant partial epilepsy.
Pereira J, Marson AG, Hutton JL. Pereira J, et al. Cochrane Database Syst Rev. 2002;(3):CD001908. doi: 10.1002/14651858.CD001908. Cochrane Database Syst Rev. 2002. PMID: 12137637 Free article. Updated. Review.
Losigamone add-on therapy for partial epilepsy.
Xiao Y, Luo M, Wang J, Luo H. Xiao Y, et al. Cochrane Database Syst Rev. 2015 Dec 10;(12):CD009324. doi: 10.1002/14651858.CD009324.pub3. Cochrane Database Syst Rev. 2015. PMID: 26661741 Updated. Review.
185 results